29 results on '"Yousefi N"'
Search Results
2. PRS23 COST-EFFECTIVENESS OF TIOTROPIUM + OLODATEROL VERSUS ACLIDINIUM + FORMOTEROL FIXED-DOSE COMBINATIONS IN THE MANAGEMENT OF MODERATE-TO-SEVERE COPD IN IRAN
3. PUK20 ECONOMIC EVALUATION OF CILOSTAZOL IN COMPARISON WITH PENTOXIFYLLINE IN THE TREATMENT OF INTERMITTENT CLAUDICATION IN IRAN
4. PDB12 COST-MINIMIZATION ANALYSIS OF INSULIN LISPRO 50/50 VERSUS INSULIN ASPART 30/70 PREMIXED FORMULATIONS IN TYPE II DIABETES
5. PRS22 THE COST EFFECTIVENESS OF DORNASE ALFA VERSUS INHALED TOBRAMYCIN IN THE MANAGEMENT OF PATIENTS WITH CYSTIC FIBROSIS
6. PCN189 COST-EFFECTIVENESS ANALYSIS OF PALBOCICLIB PLUS FULVESTRANT VERSUS EVEROLIMUS PLUS EXEMESTAN IN THE TREATMENT OF ESTROGEN RECEPTOR-POSITIVE, HER2-NEGATIVE, ADVANCED BREAST CANCER IN IRAN
7. PUK16 COST-UTILITY ANALYSIS OF MIRABEGRON VERSUS ANTIMUSCARINIC THERAPY IN THE TREATMENT OF OVERACTIVE BLADDER
8. PMU56 - ECONOMIC EVALUATION OF POSACONAZOLE IN COMPARISON WITH LIPOSOMAL AMPHOTERICIN B IN THE TREATMENT OF MUCORMYCOSIS IN IRAN
9. PMS47 - COST-EFFECTIVENESS OF TOFACITINIB COMPARED WITH ADALIMUMAB IN THE TREATMENT OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS IN IRAN
10. PIH7 - LONG-ACTING RECOMBINANT FSH (CORIFOLLITROPIN ALFA) VERSUS RECOMBINANT FSH AS ASSISTED REPRODUCTION TECHNIQUES IN THE MANAGEMENT OF INFERTILITY: A SYSTEMATIC REVIEW AND META-ANALYSIS
11. PIH40 - THE HEALTH LITERACY OF IRANIAN PARENTS: A SURVEY IN TEHRAN CAPITAL CITY
12. PHP200 - A REVIEW OF ACHIEVEMENTS AND CHALLENGES OF IRAN’S HEALTH TRANSFORMATION PLAN
13. PCN168 - COST-EFFECTIVENESS OF SORAFENIB IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA: A SYSTEMATIC REVIEW
14. PIH26 - PRACTICE TOWARD ANTIBIOTICS PREPARATION AMONG IRANIAN PARENTS
15. PCN165 - COST-EFFECTIVENESS OF SORAFENIB FOR METASTATIC RENAL CELL CARCINOMA: A SYSTEMATIC REVIEW
16. PIH27 - IRANIAN PARENTS' KNOWLEDGE ABOUT ANTIBIOTICS
17. How to Maintain Pharmaceutical Access in Crisis: The Iran FDA Experience
18. Cost-Effectiveness Analysis of Alemtuzumab In Comparison With Natalizumab, Intramuscular Interferon Beta-1a, Subcutaneous Interferon Beta-1b, And Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis In Iran
19. Relationship Between The Provision of Injection Services In Ambulatory Physician Offices And Prescribing Injectable Medicines In Iran
20. PND32 - Cost-Effectiveness Analysis of Alemtuzumab In Comparison With Natalizumab, Intramuscular Interferon Beta-1a, Subcutaneous Interferon Beta-1b, And Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis In Iran
21. PHP80 - How to Maintain Pharmaceutical Access in Crisis: The Iran FDA Experience
22. How Iranian People Think About Generic Substitution?
23. Community Pharmacist Perceptions of Generic Medicines: A Survey in Tehran
24. PIH68 - How Iranian People Think About Generic Substitution?
25. PHP126 - Community Pharmacist Perceptions of Generic Medicines: A Survey in Tehran
26. PHP179 - Relationship Between The Provision of Injection Services In Ambulatory Physician Offices And Prescribing Injectable Medicines In Iran
27. PHP126 Community Pharmacist Perceptions of Generic Medicines: A Survey in Tehran
28. PHP179 Relationship Between The Provision of Injection Services In Ambulatory Physician Offices And Prescribing Injectable Medicines In Iran
29. PIH68 How Iranian People Think About Generic Substitution?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.